Research Papers

25 of 2839 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Heteronormative biases and distinctive experiences with prostate cancer among men who have sex with men: a qualitative …
Panken E; Frydenlund N; Mistry N; Prabhu R; Wong J; Kundu S; Victorson D; Amarasekera C.
BMC Urol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prognostic significance of surgery and radiotherapy in elderly patients with localized prostate cancer: establishing an…
Zhanghuang C; Zhu J; Li Y; Wang J; Ma J; Li L; Yao Z; Ji F; Wu C; Tang H; Xie Y; Yan B; Yang Z.
BMC Urol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis.
Xu C; Geng H; Li Y; Sun F; Sun H; Zhang Y; Zhao Q.
BMC Urol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Type 2 diabetes mellitus increases the risk of circumcision among men aged between 30 and 69 years using a nationwide p…
Wu YR; Lai YH; Wang CC.
BMC Urol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Sagittal septum duplication of bladder and duplication of posterior urethra combined with congenital megacolon: a case …
Luo S; Liu J; Su P; Yu H; Li B.
BMC Urol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer…
Ma J; Hu J; Zhao L; Wu Z; Li R; Deng W.
BMC Urol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
CT findings and clinical characteristics in distinguishing renal urothelial carcinoma mimicking renal cell carcinoma fr…
Chen X; Feng X; Chen Y; Huang F; Long L.
BMC Urol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
RUNX3 pathway signature predicts clinical benefits of immune checkpoint inhibition plus tyrosine kinase inhibition in a…
Wang J; Zhang S; Wang Y; Zhu Y; Xu X; Guo J.
BMC Urol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate canc…
Borg MA; O'Callaghan ME; Moretti KL; Vincent AD.
BMC Urol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Effect of subsequent bladder cancer on survival in upper tract urothelial carcinoma patients post-radical nephrouretere…
Hu H; Lai S; Wang M; Tang X; Lai CH; Xu K; Xu T; Hu H.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies.
Banek S; Hoeh B; Cano Garcia C; Koll F; Köllermann J; Chun FKH; Mandel P; Kluth LA; Wenzel M.
Urol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrecta…
Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive value of systematic immune-inflammation index combined with Ki-67 index on prognosis of prostate cancer pati…
Wu R; Hu M; Zhang P.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Smart Diagnosis of Urinary Tract Infections: is Artificial Intelligence the Fast-Lane Solution?
Naik N; Talyshinskii A; Shetty DK; Hameed BMZ; Zhankina R; Somani BK.
Curr Urol Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prediction of T staging in PI-RADS 4-5 prostate cancer by combination of multiparametric MRI and <sup>68</sup>Ga-PSMA-1…
Ding Y; Mo C; Ding Q; Lin T; Gao J; Chen M; Lu W; Sun J; Wang F; Zang S; Zhang Q; Zhang S; Guo H.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Brazilian national prospective active surveillance (AS) cohort of patients with low-risk prostate cancer in the pub…
Basso J; de Lima JB; Bessel M; Tobar Leitão SA; Machado Baptista T; Roithmann S; Franco Carvalhal E; da Silva Schmitt C; Morzoletto Pedrollo I; Schuch A; Atalibio Hartmann A; Neubarth Estivallet CL; Behrend Silva Ribeiro G; Zordan RA; Isaacsson Velho P.
BMC Urol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar rat.
Bello II; Omigbodun A; Morhason-Bello I.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Factors affecting and effects of hemodynamic stability of pediatric patients with grades 3-5 renal trauma: a prospectiv…
Gadelkareem RA; Hamdan A; Faddan AA; Hammouda HM; Zarzour MA.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings.
Zhu S; Zhao Q; Fan Y; Tang C.
BMC Urol (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Correlation between the female pelvic floor biomechanical parameters and the severity of stress urinary incontinence.
Koroknai E; Rátonyi D; Pákozdy K; Sipos AG; Krasznai Z; Takacs P; Kozma B.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Metformin Regulates the miR-205/VEGFA Axis in Renal Cell Carcinoma Cells: Exploring a Clinical Synergism with Tyrosine …
Krebs M; Kotlyar MJ; Fahl J; Janaki Raman S; Röhrig F; Marquardt A; Kübler H; Kneitz B; Schulze A; Kalogirou C.
Urol Int (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Am…
Memik O; Voyvoda B; Ustuner M; Karsli O; Halat AO; Ozcan L.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The heat is on: the impact of excessive temperature increments on complications of laser treatment for ureteral and ren…
Tonyali S; von Bargen MF; Ozkan A; Gratzke C; Miernik A.
World J Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Initial experience with prostatic urethral lift versus enucleation of the prostate: a retrospective comparative study.
Obinata D; Uehara R; Hashimoto S; Nakahara K; Yoshizawa T; Mochida J; Yamaguchi K; Takahashi S.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms.
Lodeta B; Baric H; Hatz D; Jozipovic D; Augustin H.
BMC Urol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared